Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells

AXELSSON K.L., 1986, Tolerance to organic nitroesters in experimental animals. An assessment of in vitro and in vivo investigations, Acta Pharmacol. Toxicol., 59, 121, 10.1111/j.1600-0773.1986.tb02557.x

BERGSTRAND H., 1977, Effects of antiallergic agents, compound 40/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine 3′, 5′ cyclic monophosphate and guanosine 3′, 5′ cyclic monophosphate phosphodiesterases, Mol. Pharmacol., 13, 38

10.1016/0003-2697(76)90527-3

BRANDWEIN H.J., 1981, Reversible inactivation of guanylate cyclase by mixed disulfide formation, J. Biol. Chem., 256, 2958, 10.1016/S0021-9258(19)69708-5

10.1016/0006-2952(83)90581-6

10.1126/science.184530

10.1016/0006-291X(91)90527-E

CHIJIWA T., 1990, Inhibition of forskolin‐induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cAMP‐dependent protein kinase, N‐[2‐p‐(bromocinnamylamino)ethyl]‐5‐isoquinolinesulfonamide (H89), of PC12 pheochromocytoma cells, J. Biol. Chem., 265, 5267, 10.1016/S0021-9258(19)34116-X

10.1161/01.RES.62.4.749

10.1016/0014-5793(92)80594-7

GRUETTER C.A., 1979, Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine, J. Cyclic Nucleotide Res., 5, 211

10.1016/0014-5793(91)80871-Y

10.1111/j.1476-5381.1989.tb14603.x

HENRY P.J., 1989, Nitroglycerin‐induced tolerance affects multiple sites in the organic nitrate bioconversion cascade, J. Pharmacol. Exp. Ther., 248, 762

10.1038/194495a0

10.1146/annurev.pa.25.040185.001131

10.1016/0003-9861(86)90380-2

KATSUKI S., 1977, Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine, J. Cyclic Nucleotide Res., 3, 23

10.1016/0014-2999(93)90025-D

10.1111/j.1476-5381.1994.tb13106.x

10.1111/j.1476-5381.1991.tb12457.x

10.1172/JCI116604

LEWICKI J.A., 1983, Quantification of guanylate cyclase concentrations by a direct double determinant tandem immunoradiometric assay, J. Biol. Chem., 258, 3509, 10.1016/S0021-9258(18)32691-7

10.1096/fasebj.7.2.7680013

MAGRINAT G., 1992, Nitric oxide modulation of human leukemia cell differentiation and gene expression, Blood, 80, 1880, 10.1182/blood.V80.8.1880.1880

10.1073/pnas.88.6.2166

10.1172/JCI117637

NAKANE M., 1990, Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung, J. Biol. Chem., 265, 16841, 10.1016/S0021-9258(17)44837-X

10.1016/S0006-291X(88)80992-6

NEEDLEMAN P., 1973, Mechanism of tolerance development to organic nitrates, J. Pharmacol. Exp. Ther., 184, 709

PAPAPETROPOULOS A., 1993, Prolonged exposure to endothelium‐derived relaxing factor attenuates cyclic guanosine monophosphate accumulation in cultured smooth muscle cells, Circulation, 88, I424

10.1161/01.HYP.23.4.476

10.1161/01.HYP.26.4.696

10.1016/0003-2697(88)90338-7

10.1016/0022-2828(89)91491-0

10.1016/0003-2697(68)90092-4

SHIMOUCHI A., 1993, cAMP regulates soluble guanylate cyclase β1‐subunit gene expression in RFL‐6 rat fetal lung fibroblasts, Am. J. Physiol., 265, L456

10.1016/0014-2999(85)90527-8

10.1172/JCI116255

UJIIE K., 1994, Homologous and heterologous desensitization of guanylyl cyclase‐linked nitric oxide receptor in cultured rat medulary interstitial cells, J. Pharmacol. Exp. Ther., 270, 761

WALDMAN S.A., 1987, GMP synthesis and function, Pharmacol. Rev., 39, 163

10.1016/0003-9861(92)90139-N

10.1021/bi00501a002

10.1097/00000542-199311000-00028